Literature DB >> 8845590

Fungal urinary tract infections in the elderly: treatment guidelines.

L G Jacobs1.   

Abstract

The finding of fungal growth in the urine (funguria) of elderly patients is becoming increasingly common. It has been reported in both acute and chronic care settings. Risk factors for the development of funguria include the use of broad spectrum antibiotics, corticosteroids and indwelling bladder catheters, as well as diabetes mellitus, urological abnormalities and haematological malignancies. The presence of signs and symptoms of infection are unusual and the intensity of fungal growth in culture does not correlate with outcome. Careful assessment of the patient's clinical status should be undertaken before treatment is initiated as the majority of cases resolve when underlying risk factors are addressed. Current recommendations for treatment include bladder irrigation with amphotericin B, oral fluconazole or a single dose of intravenous amphotericin B.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845590     DOI: 10.2165/00002512-199608020-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  31 in total

1.  5-fluorocytosine treatment of candida infections of the urinary tract and other sites.

Authors:  J Schönebeck; L Steen; A Tärnvik
Journal:  Scand J Urol Nephrol       Date:  1972

2.  Treatment of fungal infections with flucytosine.

Authors:  E J Harder; P E Hermans
Journal:  Arch Intern Med       Date:  1975-02

3.  Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study.

Authors:  H S Leu; C T Huang
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

4.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

5.  Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients.

Authors:  L G Jacobs; E A Skidmore; K Freeman; D Lipschultz; N Fox
Journal:  Clin Infect Dis       Date:  1996-01       Impact factor: 9.079

6.  Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy.

Authors:  Z Nassoura; R R Ivatury; R J Simon; N Jabbour; W M Stahl
Journal:  J Trauma       Date:  1993-08

Review 7.  Yeast in the urine: solutions for a budding problem.

Authors:  J F Fisher; C L Newman; J D Sobel
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

8.  Candida-associated renal papillary necrosis.

Authors:  J F Tomashefski; C R Abramowsky
Journal:  Am J Clin Pathol       Date:  1981-02       Impact factor: 2.493

Review 9.  Fluconazole in the management of fungal urinary tract infections.

Authors:  A Voss; J F Meis; J A Hoogkamp-Korstanje
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

10.  Fungus infections of the urinary tract.

Authors:  L B GUZE; L D HALEY
Journal:  Yale J Biol Med       Date:  1958-02
View more
  5 in total

1.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

2.  Chronic urinary tract infection due to Candida utilis.

Authors:  K C Hazen; G W Theisz; S A Howell
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 3.  Treatment of systemic fungal infections in older patients: achieving optimal outcomes.

Authors:  C A Kauffman; S A Hedderwick
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Molecular Epidemiology of Anellovirus Infection in Children's Urine: A Cross-sectional Study.

Authors:  Poupak Mortazkar; Mohammad Hadi Karbalaie Niya; Davod Javanmard; Maryam Esghaei; Hossein Keyvani
Journal:  Adv Biomed Res       Date:  2020-04-22

Review 5.  Management of candiduria.

Authors:  J D Sobel; T Lundstrom
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.